Quantification of genomic loss of heterozygosity enables prospective selection of ovarian cancer patients who may derive benefit from the PARP inhib...

Date 29 September 2015
Event European Cancer Congress 2015
Session Gynaecological Cancer
Topics Ovarian Cancer
Presenter Oza, A.